论文部分内容阅读
强心甙虽然在目前仍然是最有效的治疗心功能不全的药物,但由于本品安全范围很窄,个体差异较大,除非很有经验的医生,一般难以掌握,故人们切望找到其它有效的药物。随着血流动力学研究的进展,使人们认识到,外周血管扩张药通过减轻心脏的前、后负荷,对功能不足的心肌有良好的改善作用,因而出现了一类可用于心功能不全治疗的血管扩张药。近年来人们更进一步希望找到一个兼有强心和扩血管的药物,目前已初步实现,本文介绍的就是这个药物。氨吡酮(Amrinone)既不属强心甙类,也
Although cardiac glycosides are still the most effective drugs for the treatment of cardiac insufficiency at present, due to their narrow safety range and individual differences, unless highly experienced doctors are generally difficult to grasp, they are looking for other effective drug. With the progress of hemodynamic studies, it has been recognized that peripheral vasodilators may improve cardiac insufficiency by reducing the anterior and posterior load of the heart, resulting in a class of drugs that can be used in cardiac insufficiency Vasodilator. In recent years, people further hope to find a combination of cardiac and vasodilator drugs, has initially been achieved, this article describes the drug. Amrinone is neither a cardiac glycoside nor